This literature review explored the question of which oral anticoagulant offers the best efficacy and safety for stroke prevention in non-valvular atrial fibrillation and how the nurse practitioner should select appropriate anticoagulation for these patients. The findings of this review demonstrate that warfarin remains a safe, effective and affordable therapy.Dabigatran, rivaroxaban and apixaban, offer an alternative for those patients that cannot tolerate warfarin, or who will benefit from their unique features, but further research is needed to address their limitations. The most appropriate therapy will depend on the individual context of each patient, and the nurse practitioner should assess all variables and discuss them with the patient before making a decision. Further research and surveillance are necessary to understand the role , use , side effects and impact of new oral anticoagulation in practice. This review offers recommendations that the nurse practitioner can apply to deliver care tailored to each patient. Abstract Table of Contents
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.